New in vitro models reveal importance of lung stem cells in SARS-CoV-2 infection
Researchers have developed a new 2D lung organoid in vitro model as a physiologically relevant platform to aid drug development and explore the pathogenesis of SARS-CoV-2 infection. Details were published online in Cell Stem Cell on September 18.  Discuss
Serum Institute to make Codagenix's COVID-19 vaccine
Serum Institute of India has begun manufacturing Codagenix's COVID-19 vaccine candidate, CDX-005.
Congenica launches COVID-19 genomic analysis module
Digital health company Congenica has launched a new module for its genomics analysis platform that will accelerate research into the relationship between an individual's genomic variation and COVID-19 susceptibility, severity, and clinical outcomes.
Analysis of COVID-19 literature identifies possible knowledge gaps
An analysis of COVID-19 scientific abstracts using natural language processing and machine-learning techniques suggests that the literature currently lacks basic research on the pathogenesis and viral transmission of SARS-CoV-2, according to a September 16 article published in Patterns.  Discuss
Structural changes of SARS-CoV-2 spike protein facilitate infection
The SARS-CoV-2 spike protein can adopt at least 10 sequential structural conformations when in contact with the human angiotensin-converting enzyme 2 receptor, according to a study conducted by researchers from the Francis Crick Institute and published in Nature on September 17.  Discuss
Ampio granted IND for inhaled COVID-19 therapy
Ampio Pharmaceuticals has received Investigational New Drug (IND) authorization from the U.S. Food and Drug Administration, allowing it to conduct additional clinical trials to test Ampion inhalation therapy for patients with COVID-19.
Integral Molecular touts PA grant to advance COVID-19 research
Integral Molecular was awarded over $520,000 from the state of Pennsylvania to leverage its technologies in COVID-19 research. The grant will enable the company and its partners to develop therapies and vaccines against SARS-CoV-2.
Celebration of postdocs transitions to virtual platform
For the first time ever, the National Postdoctoral Association will celebrate National Postdoc Appreciation Week from September 21-25 as a virtual, collaborative event among multiple institutions. Executive Director Tom Kimbis discusses how the organization is adapting to meet the challenges of COVID-19 to support and advocate for postdocs.  Discuss
Ufovax advances self-assembling nanoparticle COVID-19 vaccine
Vaccine biotechnology company Ufovax announced it will begin phase I clinical trials of its one-component, self-assembling protein nanoparticle (1c-SApNP) SARS-CoV-2 vaccine.
Axon Neuroscience to research COVID-19 vaccine
Clinical-stage biotechnology company Axon Neuroscience plans to start clinical trials of an independently developed, crowdfunded vaccine against COVID-19 called ACvac1.
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter